bleomycin/cytarabine/methotrexate/vincristine

Known as: ARA-C/BLEO/MTX/VCR, CytaBOM 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1987-2012
02419872012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
A 68-year-old female with palmoplantar pustulosis was referred to our hospital in July, 2009 because of liver dysfunction, a… (More)
Is this relevant?
2010
2010
OBJECTIVES The iron chelator dexrazoxane has been shown to significantly reduce anthracycline-induced cardiac toxicity in several… (More)
Is this relevant?
2007
2007
Dear Editor, Radiolabeled fluorodeoxyglucose positron emission tomography (FDG-PET), in combination with computerized tomography… (More)
  • figure 1
Is this relevant?
1996
1996
From May 1985 to May 1989, 175 patients with previously untreated aggressive non-Hodgkin's lymphoma were randomized to receive… (More)
Is this relevant?
1995
1995
The authors describe one case of a rare primitive non-Hodgkin lymphoma of the uterus, and two cases of primary non-Hodgkin… (More)
Is this relevant?
1995
1995
It has been previously demonstrated that the administration of recombinant human granulocyte-colony stimulating factor (rhG-CSF… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
BACKGROUND CHOP is a first-generation, combination-chemotherapy regimen consisting of cyclophosphamide, doxorubicin, vincristine… (More)
Is this relevant?
1991
1991
Two recent reports of the same combination chemotherapy program, cyclophosphamide, doxorubicin, etoposide, methotrexate… (More)
Is this relevant?
1988
1988
An unusual case of an aggressive leukemia of natural killer (NK) cells occurred in a 65-year-old male. Clinical characteristics… (More)
Is this relevant?